BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 31090458)

  • 1. Three probiotic strains exert different effects on plasma bile acid profiles in healthy obese adults: randomised, double-blind placebo-controlled crossover study.
    Culpepper T; Rowe CC; Rusch CT; Burns AM; Federico AP; Girard SA; Tompkins TA; Nieves C; Dennis-Wall JC; Christman MC; Langkamp-Henken B
    Benef Microbes; 2019 May; 10(5):497-509. PubMed ID: 31090458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Bacillus subtilis R0179 on gastrointestinal viability and general wellness: a randomised, double-blind, placebo-controlled trial in healthy adults.
    Hanifi A; Culpepper T; Mai V; Anand A; Ford AL; Ukhanova M; Christman M; Tompkins TA; Dahl WJ
    Benef Microbes; 2015 Mar; 6(1):19-27. PubMed ID: 25062611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probiotic or synbiotic alters the gut microbiota and metabolism in a randomised controlled trial of weight management in overweight adults.
    Hibberd AA; Yde CC; Ziegler ML; Honoré AH; Saarinen MT; Lahtinen S; Stahl B; Jensen HM; Stenman LK
    Benef Microbes; 2019 Mar; 10(2):121-135. PubMed ID: 30525950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix Effects on the Delivery Efficacy of Bifidobacterium animalis subsp.
    Ba Z; Lee Y; Meng H; Kris-Etherton PM; Rogers CJ; Lewis ZT; Mills DA; Furumoto EJ; Rolon ML; Fleming JA; Roberts RF
    mSphere; 2021 Aug; 6(4):e0008421. PubMed ID: 34232082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of Bifidobacterium animalis ssp. lactis B94 on gastrointestinal wellness in adults with Prader-Willi syndrome: study protocol for a randomized controlled trial.
    Alyousif Z; Miller JL; Sandoval MY; MacPherson CW; Nagulesapillai V; Dahl WJ
    Trials; 2018 Apr; 19(1):256. PubMed ID: 29703235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of yoghurt and its probiotics on blood pressure and serum lipid profile; a randomised controlled trial.
    Ivey KL; Hodgson JM; Kerr DA; Thompson PL; Stojceski B; Prince RL
    Nutr Metab Cardiovasc Dis; 2015 Jan; 25(1):46-51. PubMed ID: 25171898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Bifidobacterium animalis subsp. lactis BB-12 and, Lactobacillus acidophilus LA-5-containing yoghurt, on fecal bacterial counts of healthy adults.
    Savard P; Lamarche B; Paradis ME; Thiboutot H; Laurin É; Roy D
    Int J Food Microbiol; 2011 Sep; 149(1):50-7. PubMed ID: 21296446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lactobacillus acidophilus 74-2 and Bifidobacterium animalis subsp lactis DGCC 420 modulate unspecific cellular immune response in healthy adults.
    Klein A; Friedrich U; Vogelsang H; Jahreis G
    Eur J Clin Nutr; 2008 May; 62(5):584-93. PubMed ID: 17440520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of 28-day Bifidobacterium animalis subsp. lactis HN019 supplementation on colonic transit time and gastrointestinal symptoms in adults with functional constipation: A double-blind, randomized, placebo-controlled, and dose-ranging trial.
    Ibarra A; Latreille-Barbier M; Donazzolo Y; Pelletier X; Ouwehand AC
    Gut Microbes; 2018; 9(3):236-251. PubMed ID: 29227175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Bifidobacterium animalis subsp. lactis BB-12
    Lee Y; Ba Z; Roberts RF; Rogers CJ; Fleming JA; Meng H; Furumoto EJ; Kris-Etherton PM
    Nutr J; 2017 Jun; 16(1):39. PubMed ID: 28662676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the probiotic strain Bifidobacterium animalis subsp. lactis, BB-12®, on defecation frequency in healthy subjects with low defecation frequency and abdominal discomfort: a randomised, double-blind, placebo-controlled, parallel-group trial.
    Eskesen D; Jespersen L; Michelsen B; Whorwell PJ; Müller-Lissner S; Morberg CM
    Br J Nutr; 2015 Nov; 114(10):1638-46. PubMed ID: 26382580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of probiotic supplementation on glycaemic control and lipid profiles in gestational diabetes: A randomized, double-blind, placebo-controlled trial.
    Karamali M; Dadkhah F; Sadrkhanlou M; Jamilian M; Ahmadi S; Tajabadi-Ebrahimi M; Jafari P; Asemi Z
    Diabetes Metab; 2016 Sep; 42(4):234-41. PubMed ID: 27209439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PHAGE-2 Study: Supplemental Bacteriophages Extend
    Grubb DS; Wrigley SD; Freedman KE; Wei Y; Vazquez AR; Trotter RE; Wallace TC; Johnson SA; Weir TL
    Nutrients; 2020 Aug; 12(8):. PubMed ID: 32824480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lactobacillus gasseri KS-13, Bifidobacterium bifidum G9-1, and Bifidobacterium longum MM-2 Ingestion Induces a Less Inflammatory Cytokine Profile and a Potentially Beneficial Shift in Gut Microbiota in Older Adults: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study.
    Spaiser SJ; Culpepper T; Nieves C; Ukhanova M; Mai V; Percival SS; Christman MC; Langkamp-Henken B
    J Am Coll Nutr; 2015; 34(6):459-69. PubMed ID: 25909149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-response study of probiotic bacteria Bifidobacterium animalis subsp lactis BB-12 and Lactobacillus paracasei subsp paracasei CRL-341 in healthy young adults.
    Larsen CN; Nielsen S; Kaestel P; Brockmann E; Bennedsen M; Christensen HR; Eskesen DC; Jacobsen BL; Michaelsen KF
    Eur J Clin Nutr; 2006 Nov; 60(11):1284-93. PubMed ID: 16721394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of a probiotic blend on gastrointestinal symptoms in constipated patients: a double blind, randomised, placebo controlled 2-week trial.
    Airaksinen K; Yeung N; Lyra A; Lahtinen SJ; Huttunen T; Shanahan F; Ouwehand AC
    Benef Microbes; 2019 Jul; 10(6):617-627. PubMed ID: 31131616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbiota profile and efficacy of probiotic supplementation on laxation in adults affected by Prader-Willi Syndrome: A randomized, double-blind, crossover trial.
    Alyousif Z; Miller JL; Auger J; Sandoval M; Piano A; Tompkins TA; Dahl WJ
    Mol Genet Genomic Med; 2020 Dec; 8(12):e1535. PubMed ID: 33103385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Xylo-oligosaccharides alone or in synbiotic combination with Bifidobacterium animalis subsp. lactis induce bifidogenesis and modulate markers of immune function in healthy adults: a double-blind, placebo-controlled, randomised, factorial cross-over study.
    Childs CE; Röytiö H; Alhoniemi E; Fekete AA; Forssten SD; Hudjec N; Lim YN; Steger CJ; Yaqoob P; Tuohy KM; Rastall RA; Ouwehand AC; Gibson GR
    Br J Nutr; 2014 Jun; 111(11):1945-56. PubMed ID: 24661576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eight Weeks of
    Li T; Rui Z; Mao L; Chang Y; Shao J; Chen Y; Han Q; Sui X; An N; Li H; Feng H; Jiang T; Wang Q
    Nutrients; 2023 Oct; 15(21):. PubMed ID: 37960207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-obesity properties of the strain Bifidobacterium animalis subsp. lactis CECT 8145 in Zücker fatty rats.
    Carreras NL; Martorell P; Chenoll E; Genovés S; Ramón D; Aleixandre A
    Benef Microbes; 2018 Jun; 9(4):629-641. PubMed ID: 29695181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.